One of the University of Kansas’
most ambitious goals is for its Cancer
Center to achieve designation by the
National Cancer Institute (NCI) within
10 years. NCI-designated cancer centers
are considered the leaders in cancer
research and care and in the discovery of
better approaches to cancer prevention,
diagnosis, and therapy.
One of the key criteria of achieving NCI
designation is the ability to demonstrate
collaborations with key hospitals and
research institutions that are committed
to advancing cancer research in the
region. The KU Cancer Center, through
the Midwest Cancer Alliance (MCA), is
bringing together a dedicated group
of CEOs from top-flight hospitals and
research organizations that are invested
in the effort to secure NCI designation
for the region.
This MCA Partners Advisory Board (PAB)
is serving as a kind of “kitchen cabinet”
to advise Roy Jensen, MD, director of the
University of Kansas Cancer Center and
CEO of the Midwest Cancer Alliance.
“In order to achieve NCI designation, we
need to demonstrate that this is a region
that collaborates together in an effort
to cure cancer,” Jensen said. “We are
fortunate to have a number of excellent
health systems and research institutions
in the area, and we need to leverage that
expertise to achieve this designation.”
The current members of the MCA
PAB include:
- Children’s Mercy Hospitals and Clinics
- Kansas Bioscience Authority
- Kansas State University
- The University of Kansas Hospital
- Truman Medical Center
- Saint Luke’s Health System
- Stormont-Vail HealthCare
- Stowers Institute for Medical Research
- University of Kansas Medical Center
- Via Christi Health System
©
The University of Kansas Medical Center